[1] Franklin NT, Willian D, Edward GG, et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee[J]. J Am Coll Radiol. 2017; 14:587-595.
[2] Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the united states, 1974-2013[J]. JAMA.2017;317(13):1338-1348. DOI:10.1001/jama.2017.2719.
[3] Kim SY, Kwak JY, Kim EK, et al. Association of preoperative US features and recurrence in patients with classic papillary thyroid carcinoma[J]. Radiology. 2015;277(2):574-583. DOI:10.1148/radiol.2015142470.
[4] Li JW, Chang C, Chen M, et al. Identification of calcifications in thyroid nodules: comparison between
ultrasonography and CT[J]. Chin J Ultrasonogr.2017; 26(5):313-317.
DOI:10.3760/cma.j.issn.1004-4477.2017.05.012.
[5] Zhu Q, Li JW, Zhou SC, Chang C, Chen M, Fan YW. Diagnostic value of ultrasonography in predicting neck lymph node metastasis in Hashimoto’s thyroiditis with papillary thyroid carcinoma[J]. Chin J Ultrasonogr. 2016; 25(11):962-965. DOI:10.3760/cma.j.issn.1004-4477.2016.11.011.
[6] Chinese Association of Thyroid Oncology (CATO). Chinese experts’ consensus on diagnosis and treatment of thyroid micropapillary carcinoma (2016 Edition). Chin J Clin Oncol. 2016;43(10):405-411.
[7] Chinese Thyroid Association (CTA), Thyroid Committee of Chinese Research Hospital Association. Expert consensus on lymph node dissection in cervical region of differentiated thyroid cancer (2017 Edition) [J]. Chin J Practical Surg. 2017;37(9):985-991.
[8] Wang TS, Evans DB. Commentary on: Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study[J]. Surgery,.2017; 161(2):472-474.
[9] Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid.2016; 26(1). DOI:10.1089/thy.2015.0020.
[10] Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13MHz) ultrasound examination. Eur J Clin Invest.2009; 39:699-706.
[11] Singh Ospina N, Brito JP, Maraka S, et al. Diagnostic accuracy of ultrasound-guided fine needle aspiration biopsy for thyroid malignancy: systematic review and meta-analysis. Endocrine.2016;53:651-661.
[12] Simth-Bindman R, Lebda P, Feldstein VA, et al. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study. JAMA Intern Med. 2013; 173:1788-1796.
[13] Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014; 140:317-322.
[14] Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J].2016; 26(1):1-133. DOI:10.1089/thy.2015.0020.
[15] Park JP, Roh JL, Lee JH, et al. Risk factors for central neck lymph node metastasis of clinically noninvasive, node-negative papillary thyroid microcarcinoma[J]. Am J Surg. 2014; 208(3):412-418. DOI:10.1016/j. amjsurg. 2013.10.032.
[16] Zeng RC, Zhang W, Gao EL, et al. Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma[J]. Head Neck. 2014; 36(1):101-106.
[17] Kim KE, Kim EK, Yoon JH, Han KH, Moon HJ, Kwak JY. Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features[J]. Word J Surg. 2013; 37(2):385-391.
[18] Lee YS, Shin SC, Lim YS, et al. Tumour location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer[J]. Head Nek. 2014; 36(6):887-891. DOI: 10.1002/hed.23391.
[19] Lei J, Zhong J, Jiang K, Li Z, Gong R, Zhu J. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma[J]. Oncotarget. 2017; 8(16): 27022-27033. DOI:10.18632/ oncotarget.15388.
[20] AL AA, Williams BA, Rigby MH, et al. Multifocal papillary thyroid cancer increases the risk of central lymph node metastasis[J]. Thyroid.2015; 25(9):1008-1012. DOI:10.1089/thy. 2015.0130.
[21] Lin DZ, Qu N, Shi RL, Lu ZW, Ji QH, Wu WL. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma[J]. Onco Targets Ther. 2016; 9:5307-5316.
DOI:10.2147/OTT.S107913.
[22] Qu N, Zhang L, Lin DZ, et al. The impact of coexistent Hashimoto’s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma[J]. Tumour Biol.2016; 37(6):7685-7692. DOI:10.1007/s13277-015-4534-4.
[23] Lee YS, Jeong JJ, Nam KH, Chung WY, Chang HS, Park CS. Papillary carcinoma located in the thyroid isthmus[J]. World J Surg.2010; 34(1): 36-39.
[24] Fan FJ, Qin L, Ding HY, Liu DQ, Jia JY, Tan Z. Study on ultrasound image features of papillary thyroid carcinoma originating in the isthmus [J]. Chin J Clinicians (Electronic Edition).2015; 9(20): 3720-3723.
[25] Xiang D, Xie L, Xu Y, Li Z, Hong Y, Wang P. Papillary thyroid microcarcinomas located at the middle part of the middle third of the thyroid gland correlates with the presence of neck metastasis[J]. Surgery. 2015; 157(3):526-533. DOI:10.1016/ j. surg. 2014.10.020.
[26] Sun W, Lan X, Zhang H, et al. Risk factors for central lymph node metastasis in CN0 papillary thyroid carcinoma: a systematic review and meta-analysis[J]. PLoS One.2015; 10(10): e0139021. DOI:10.1371/ journal. pone. 0139021.
[27] Kwak JY, Han KH, Yoon JH, et al. Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk. Radiology. 2011; 260:892-899.
[28] Na DG, Baek JH, Sung JY, et al. Thyroid imaging reporting and data system risk stratification of thyroid nodules: categorization based on solidity and echogenicity. Thyroid. 2016; 26:562-572.
[29] Nam SY, Shin JH, Han BK, et al. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior[J]. J Clin Endocrinol Metab. 2013; 98(4):1476-1482.
[30] Zhou J, Zhou SC, Li JW, et al. Risk factors of central neck lymph node metastasis following solitary papillary thyroid carcinoma[J]. Chin J Ultrasonogr. 2019; 28(3):235-240.
[31] Deng SP, Xiong HH, Li QS, et al. Ultrasonographic characteristics of papillary thyroid cancer: predicting factors of lateral lymph node metastasis[J]. Chinese J Ultrasound Med. 2017; 33(3):196-198.
[32] Heaton CM, Chang JL, Orloff LA. Prognostic implications of lymph node yield in central and lateral neck dissections for well-differentiated papillary thyroid carcinoma[J]. Thyroid. 2016;26(3):434-440.
[33] Lan Y, Song Q, Jin Z, Zhang Y, Lin L, Luo YK. Correction of routine ultrasound features and BRAFV600E gene to the cervical lymph node metastasis of thyroid papillary carcinoma[J]. Med J Chin PLA.2019; 44(9):747-752.
[34] Deng SP, Li QS, Chen SH, et al. Analysis of related factors on cervical lymph node metastasis and ultrasonographic characteristics of papillary thyroid microcarcinoma[J]. J Clin Ultrasound in Med. 2017; 19(6):424-426.
[35] Oh EM, Chung YS, Song WJ, Lee YD. The pattern and significance of the calcifications of papillary thyroid microcarcinoma presented in preoperative neck ultrasonography[J]. Ann Surg Treat Res. 2014; 86(3):115-121.
[36] Shi C, Li S, Shi T, Liu B, Ding C, Qin H. Correlation between thyroid nodule calcification morphology on ultrasound and thyroid carcinoma[J]. J Int Med Res. 2012; 40(1):350-357.
[37] Bai Y, Zhou G, Nakamura M, et al. Survival impact of psammoma body, stromal calcification and bone formation in papillary thyroid carcinoma[J]. Mod Pathol. 2009; 22(7):887-894.
[38] Sun YS, Lv HJ, Zhao YR, Shi BY. Risk factors for central neck lymph node metastases of papillary thyroid carcinoma[J]. Chin J Otorhinolaryngol Head Nexk Surg. 2017; 52(6):421-425.
[39] Heaton CM, Chang JL, Orloff LA. Prognostic implications of lymph node yield in central and lateral neck dissections for well-differentiated papillary thyroid carcinoma[J]. Thyroid, 2016,26(3):434-440.
[40] Zheng G, Zhang H, Hao S, Liu C, Xu J. Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis[J]. Oncotarget, 2017, 8(34):57089-57098.
[41] Xiang D, Xie L, Xu Y, et al. Papillary thyroid microcarcinomas located at the middle part of the middle thyroid of the thyroid gland correlates with the presence of neck metastasis[J]. Surgery, 2015, 157(3):526-533. DOI:10.1016/j.surg.2014.10.020.